Literature DB >> 11331395

Differential contribution of substance P and neurokinin A to spinal cord neurokinin-1 receptor signaling in the rat.

J A Trafton1, C Abbadie, A I Basbaum.   

Abstract

Although the tachykinins substance P (SP) and neurokinin A (NKA) are coreleased from primary afferent nociceptors and act via neurokinin (NK) receptors, their differential effects in vivo are not known. Despite pharmacological evidence that NKA preferentially binds NK-2 receptors, this receptor is not found in spinal cord neurons. Thus, in the present studies, we compared the extent to which SP and NKA contribute to spinal nociceptive processing via the NK-1 receptor. We found that SP and NKA induce NK-1 receptor internalization with identical dose dependence and induce increases in intracellular calcium at the same concentrations, suggesting that SP and NKA equally activate the NK-1 receptor. We found, however, that the selective NK-1 receptor antagonist GR 205171 blocked NKA but not SP-induced NK-1 receptor internalization in the rat spinal cord in vivo and in embryonic day 19 rat spinal neurons in vitro. Using this selectivity of GR 205171 for NKA-induced NK-1 receptor activation, we examined the relative contribution of SP and NKA to noxious stimulus-induced activation of spinal NK-1 receptors. We estimate that NKA contributes to at least 50% of the NK-1 receptor activation in lamina I. Under inflammatory conditions, all noxious stimulus-induced NK-1 receptor internalization in deep dorsal horn neurons was blocked by GR 205171, suggesting that it is entirely NKA-mediated. Substance P-mediated NK-1 receptor internalization was focused at the site of termination of stimulated nociceptors but NKA also activated NK-1 receptors at more distant sites. We conclude that NKA not only targets the NK-1 receptor but may be a predominant pronociceptive primary afferent neurotransmitter.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11331395      PMCID: PMC6762493     

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  32 in total

1.  Release and spread of immunoreactive neurokinin A in the cat spinal cord in a model of acute arthritis.

Authors:  P J Hope; B Jarrott; H G Schaible; R W Clarke; A W Duggan
Journal:  Brain Res       Date:  1990-11-19       Impact factor: 3.252

2.  Physiological and pharmacological characterization of the spinal tachykinin NK2 receptor.

Authors:  M Lepre; H R Olpe; R H Evans; F Brugger
Journal:  Eur J Pharmacol       Date:  1994-06-02       Impact factor: 4.432

3.  The effects of neurokinin receptor antagonists on mustard oil-evoked activation of rat dorsal horn neurons.

Authors:  F E Munro; S M Fleetwood-Walker; R M Parker; R Mitchell
Journal:  Neuropeptides       Date:  1993-11       Impact factor: 3.286

4.  The role of spinal neurokinin-2 receptors in the processing of nociceptive information from the joint and in the generation and maintenance of inflammation-evoked hyperexcitability of dorsal horn neurons in the rat.

Authors:  V Neugebauer; P Rumenapp; H G Schaible
Journal:  Eur J Neurosci       Date:  1996-02       Impact factor: 3.386

5.  Electrophysiological evidence that neurokinin A acts via NK-1 receptors in the cat dorsal horn.

Authors:  V Radhakrishnan; J L Henry
Journal:  Eur J Neurosci       Date:  1997-09       Impact factor: 3.386

6.  Characterization of antibodies to the rat substance P (NK-1) receptor and to a chimeric substance P receptor expressed in mammalian cells.

Authors:  S R Vigna; J J Bowden; D M McDonald; J Fisher; A Okamoto; D C McVey; D G Payan; N W Bunnett
Journal:  J Neurosci       Date:  1994-02       Impact factor: 6.167

7.  Evidence for a role of tachykinin NK2 receptors in mediating brief nociceptive inputs to rat dorsal horn (laminae III-V) neurons.

Authors:  S M Fleetwood-Walker; R M Parker; F E Munro; M R Young; P J Hope; R Mitchell
Journal:  Eur J Pharmacol       Date:  1993-09-28       Impact factor: 4.432

8.  Human substance P receptor expressed in Chinese hamster ovary cells directly activates G(alpha q/11), G(alpha s), G(alpha o).

Authors:  E D Roush; M M Kwatra
Journal:  FEBS Lett       Date:  1998-05-29       Impact factor: 4.124

9.  Differential effects of selective tachykinin NK2 receptor antagonists in rat spinal cord.

Authors:  Z Wiesenfeld-Hallin; L Luo; X J Xu; C A Maggi
Journal:  Eur J Pharmacol       Date:  1994-01-04       Impact factor: 4.432

10.  Characterization of substance P(1-7) and (1-8) generating enzyme in human cerebrospinal fluid.

Authors:  F Nyberg; P Le Greves; C Sundqvist; L Terenius
Journal:  Biochem Biophys Res Commun       Date:  1984-11-30       Impact factor: 3.575

View more
  18 in total

1.  Src family kinases mediate the inhibition of substance P release in the rat spinal cord by μ-opioid receptors and GABA(B) receptors, but not α2 adrenergic receptors.

Authors:  Guohua Zhang; Wenling Chen; Juan Carlos G Marvizón
Journal:  Eur J Neurosci       Date:  2010-08-19       Impact factor: 3.386

2.  Noxious mechanical stimulation evokes the segmental release of opioid peptides that induce mu-opioid receptor internalization in the presence of peptidase inhibitors.

Authors:  Lijun Lao; Bingbing Song; Wenling Chen; Juan Carlos G Marvizón
Journal:  Brain Res       Date:  2008-01-03       Impact factor: 3.252

3.  Quantitative mass spectrometry analysis reveals that deletion of the TRPV1 receptor in mice alters substance P and neurokinin A expression in the central nervous system.

Authors:  Floriane Pailleux; Jérôme Lemoine; Francis Beaudry
Journal:  Neurochem Res       Date:  2012-08-10       Impact factor: 3.996

4.  Substance P and calcitonin gene related peptide mediate pain in chronic pancreatitis and their expression is driven by nerve growth factor.

Authors:  LianSheng Liu; Mohan Shenoy; Pankaj Jay Pasricha
Journal:  JOP       Date:  2011-07-08

5.  Peptidases prevent mu-opioid receptor internalization in dorsal horn neurons by endogenously released opioids.

Authors:  Bingbing Song; Juan Carlos G Marvizón
Journal:  J Neurosci       Date:  2003-03-01       Impact factor: 6.167

6.  PACAP and Other Neuropeptide Targets Link Chronic Migraine and Opioid-induced Hyperalgesia in Mouse Models.

Authors:  Krishna D. B. Anapindi; Ning Yang; Elena V Romanova; Stanislav S Rubakhin; Alycia Tipton; Isaac Dripps; Zoie Sheets; Jonathan V Sweedler; Amynah A Pradhan
Journal:  Mol Cell Proteomics       Date:  2019-10-24       Impact factor: 5.911

7.  μ-Opioid receptor inhibition of substance P release from primary afferents disappears in neuropathic pain but not inflammatory pain.

Authors:  W Chen; J A McRoberts; J C G Marvizón
Journal:  Neuroscience       Date:  2014-02-26       Impact factor: 3.590

8.  Acute inflammation induces segmental, bilateral, supraspinally mediated opioid release in the rat spinal cord, as measured by mu-opioid receptor internalization.

Authors:  W Chen; J C G Marvizón
Journal:  Neuroscience       Date:  2009-03-17       Impact factor: 3.590

9.  NMDA receptors in primary afferents require phosphorylation by Src family kinases to induce substance P release in the rat spinal cord.

Authors:  W Chen; G Zhang; J C G Marvizón
Journal:  Neuroscience       Date:  2010-01-13       Impact factor: 3.590

10.  Spinal N-methyl-D-aspartate receptors and nociception-evoked release of primary afferent substance P.

Authors:  A Nazarian; G Gu; N G Gracias; K Wilkinson; X Y Hua; M R Vasko; T L Yaksh
Journal:  Neuroscience       Date:  2008-03-03       Impact factor: 3.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.